Wordt geladen...
Pulmonary pleomorphic carcinoma: A case harboring EGFR mutation treated with EGFR‐TKIs
Pulmonary pleomorphic carcinoma (PPC) is a very rare type of primary lung cancer with an aggressive clinical course. Few reports have documented therapeutic options for PPC with EGFR mutations. Herein, we report a case of PPC with EGFR mutation treated with EGFR‐tyrosine kinase inhibitors (TKIs). A...
Bewaard in:
| Gepubliceerd in: | Thorac Cancer |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons Australia, Ltd
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5983202/ https://ncbi.nlm.nih.gov/pubmed/29675860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12646 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|